'Follow zero tolerance': Health minister on cough syrup deaths

Asserting that India follows a zero-tolerance policy on spurious medicines, Union health minister Mansukh Mandaviya has said 71 companies have been issued show-cause notices following concerns......

India among top 10 countries with highest Type 1 diabetes prevalence: Lancet

An estimated 8.4 million people were living with Type 1 diabetes across the globe in 2021, and India was among the top ten countries with highest prevalence of the disease, according to a modelling......

Covovax nod to boost vaccination drive in India: SII

Vaccine major Serum Institute of India on Tuesday said the approval for the COVID-19 vaccine 'Covovax' would strengthen immunization initiatives across India and various lower and middle income......

UK, India COVID-19 study sets Guinness world record

A worldwide COVID-19 study led by UK experts and conducted at Indian hospitals among others around the world has been awarded the 'Guinness World Records' title for the world's largest scientific......

India's external debt rises 8.2% to $620.7 bn till Mar 2022

India's external debt rose by 8.2 per cent year-on-year to $620.7 billion as of March 2022, which according to the finance ministry is sustainable. While 53.2 per cent of it was denominated in the......

Survey bats for enhanced govt spending in healthcare

An increase in government spending on the healthcare sector - from the current 1 per cent to 2.5-3 per cent of GDP - as envisaged in the National Health Policy 2017 could reduce out-of-pocket......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......